HuagongsheHuagongshe Chemistry Print Report · For research reference only
(3-Methyl-1,2,4-oxadiazol-5-yl)methanamine → 5-cyclohexyl-N-(3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (3-Methyl-1,2,4-oxadiazol-5-yl)methanamine | HCID 10844548 | — |
| Reactant | 5-Cyclohexyl-6-(2,2,2-trifluoroethoxy)nicotinic acid | HCID 71293952 | — |
| Product | 5-cyclohexyl-N-(3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide | HCID 71294233 | — |
Reaction Steps
This compound was prepared following the same procedure as described in Example 11 using 5-cyclohexyl-6-(2,2,2-trifluoro-ethoxy)-nicotinic acid (Example 4b) (100 mg, 0.33 mmol) and 3-methyl-1,2,4-oxadiazole-5-methanamine (CAN 90928-92-0) (37 mg, 0.33 mmol) as starting materials; off white solid (30 mg, 22.9%). MS (ESI): 399 (M+H)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08629166B2 |
| Source dataset | uspto-grants-2014_01 |
| ORD ID | ord-fc4bbee5786045e18ee69b83a88e58fc |
| Source note | uspto-grants-2014_01 |